Anne Lynn S. Chang, MD
Academic Appointments
- Assistant Professor - Med Center Line, Dermatology
- Member, Stanford Cancer Institute
- Member, Child Health Research Institute
Key Documents
Contact Information
-
Clinical Offices
Medical Dermatology 450 Broadway ST Pav B FL 4 MC 5338 Redwood City, CA 94063 Tel Work (650) 723-6316 Fax (650) 721-3476Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Administrative Contact Olena Mykhaylichenko Administrative Associate Email Tel Work 650-721-7193Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cutaneous (Dermatologic) Oncology
- Dermatology
- Geriatric dermatology
- Aging of the Skin
- Skin Cancer
- basal cell carcinoma
Administrative Appointments
- Director of the Advanced Basal Cell Carcinoma Clinic, Stanford Dermatology (2011 - present)
- Director of Adult Dermatological Clinical Trials, Stanford Dermatology (2007 - present)
Honors and Awards
- Research Scholar Award, American Skin Association (2013)
- Career Development Award, Dermatology Foundation (2009)
- Fellow, American Academy of Dermatology (2007)
Professional Education
| Residency: | Stanford University Hospital & Clinics - Dermatology Department, CA USA (2007) |
| Residency: | UCSF - Department of OB/GYN & REI CA (2002) |
| Medical Education: | Harvard Medical School MA (1999) |
| Board Certification: | Dermatology, American Board of Dermatology (2007) |
| Fellowship: | Stanford University Hospital & Clinics - Dermatology Department, CA USA (2004) |
| Internship: | UCSF - Department of OB/GYN & REI CA (2000) |
Internet Links
Scientific Focus
Current Research Interests
Our current studies focus on aging and skin cancers in human beings and are translational in nature:
1) genetics and epigenetics to promote healthy aging of the skin
2) genetics and epigenetics of skin cancers and drug resistance
3) novel therapies to promote healthy aging of the skin
4) novel therapies for non-melanoma skin cancers
5) induced pluripotent stem cells for regenerative and therapeutic purposes
Clinical Trials
- Recruiting An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC)
- Recruiting Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors
- Recruiting Vismodegib in Treating Patients With Basal Cell Carcinoma
- Not Recruiting A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell Carcinoma
- Not Recruiting A Study of Pharmacokinetic Drug Interaction Study of the Hedgehog Pathway Inhibitor GDC-0449 in Combination With Rosiglitazone or Combined Oral Contraceptive in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists
Publications
- Geriatric dermatology review: major changes in skin function in older patients and their contribution to common clinical challenges JAMDA.
- Phase 1 Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors Cancer Clinical Research, doi:10.1158/1078-0432.CCR-12-3654.
- Geriatric Dermatology. Part 1. Geriatric pharmacology for the dermatologist Journal of the American Academy of Dermatology. 2013; (4): 521e1-e10
- Geriatric Dermatology. Part 2. Risk factors and cutaneous signs of elder mistreatment for the dermatologist Journal of the American Academy of Dermatology. 2013; (4): 533e1-e10
- Markedly improved overall survival in 10 consecutive metastatic basal cell carcinoma patients. Br J Dermatol. 2013
- New onset of keratoacanthomas after vismodegib for locally advanced basal cell carcinomas: a report of two cases JAMA Dermatology. 2013; (2): 242-3
Help
Trial Administration